Loading…

P494 A serum metabolite panel predicts Crohn’s disease relapse in patients discontinuing infliximab and continuing antimetabolite therapy: sub-analysis of the SPARE Trial

Saved in:

Bibliographic Details
Published in:	Journal of Crohn's and colitis 2022-01, Vol.16 (Supplement_1), p.i458-i460
Main Authors:	Radford-Smith, D, Satsangi, J, Louis, E, Laharie, D, Ding, N, Siegmund, B, D’Haens, G, Erik, H, Yates, A, Anthony, D, Colombel, J F, Probert, F
Format:	Article
Language:	English
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!